Seeking Alpha

Guggenheim sees big upside for Tetraphase

  • Tetraphase Pharmaceuticals (TTPH +5.3%)  is trading notably higher on the session.
  • Likely helping the cause is Guggenheim, where analysts initiated the shares at Buy.
  • Price target is $25, representing upside of around 144% from Tuesday's close.
Comments (1)
  • Rhinoish
    , contributor
    Comments (83) | Send Message
    Its gonna take a couple years for FDA approval, but $25? eventually yeah it'll get there, if its not bought out
    14 Nov 2013, 02:45 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: